Difficulty: Medium
Average Score: 73%
Practice
A 36-year-old male has been smoking 2 packs of cigarettes a day for the last 20 years. He has tried nicotine patches with no success and wants to know if there is any 'pill he could try'. What medication could the physician recommend?
Correct answer
D
Rationale
In this scenario, the physician could recommend Bupropion (Option D) for the patient who has been smoking heavily and struggling with nicotine replacement therapy. Bupropion is a medication commonly used as a smoking cessation aid due to its ability to reduce nicotine withdrawal symptoms and cravings by affecting neurotransmitters in the brain. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) that helps to alleviate the addictive behavior associated with smoking.
Option A, Citalopram, is a selective serotonin reuptake inhibitor (SSRI) used primarily for treating depression and anxiety disorders, not smoking cessation. Option B, Phenelzine, is a monoamine oxidase inhibitor (MAOI) used for depression and anxiety disorders, not smoking cessation. Option C, Buspirone, is an anxiolytic agent used for generalized anxiety disorder, not smoking cessation.
From an educational perspective, it is important for healthcare providers to understand the specific pharmacological mechanisms of drugs when recommending treatments. Bupropion's efficacy in smoking cessation is well-supported by clinical evidence, making it a suitable choice for patients like the one presented in the question who have struggled with quitting smoking through other means. Understanding the appropriate use of medications based on their mechanisms of action is crucial in providing effective patient care.
Option A, Citalopram, is a selective serotonin reuptake inhibitor (SSRI) used primarily for treating depression and anxiety disorders, not smoking cessation. Option B, Phenelzine, is a monoamine oxidase inhibitor (MAOI) used for depression and anxiety disorders, not smoking cessation. Option C, Buspirone, is an anxiolytic agent used for generalized anxiety disorder, not smoking cessation.
From an educational perspective, it is important for healthcare providers to understand the specific pharmacological mechanisms of drugs when recommending treatments. Bupropion's efficacy in smoking cessation is well-supported by clinical evidence, making it a suitable choice for patients like the one presented in the question who have struggled with quitting smoking through other means. Understanding the appropriate use of medications based on their mechanisms of action is crucial in providing effective patient care.